Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Turner

Showing results (1091-1100 of 1,195) with videos related to

Pageof 120
Sort By:
Clinical and Translational Medicine|November 10, 2023
Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsisHu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Deep Phenotyping of the Lipidomic Response in COVID and non-COVID SepsisHu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Anesthesia and Analgesia|April 8, 2021
The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United StatesDaniel Katz, Brian T Bateman, Klaus Kjaer, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
Nucleic Acids Research|November 16, 2017
Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response dataAmar Koleti, Raymond Terryn, Vasileios Stathias, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Critical Care Explorations|December 8, 2022
Validating a Proteomic Signature of Severe COVID-19Christopher V Cosgriff, Todd A Miano, Divij Mathew, et al.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Allergy|March 27, 2015
Precautionary allergen labelling: perspectives from key stakeholder groupsA DunnGalvin, C-H Chan, R Crevel, et al.
CMAJ Open|March 18, 2021
Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology studyCorinne M Hohl, Rhonda J Rosychuk, Andrew D McRae, et al.
Pageof 120

Showing results (1091-1100 of 1,195) with videos related to

Sort By:
Pageof 120
Clinical and Translational Medicine|November 10, 2023
Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsisHu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Deep Phenotyping of the Lipidomic Response in COVID and non-COVID SepsisHu Meng, Arjun Sengupta, Emanuela Ricciotti, et al.
Anesthesia and Analgesia|April 8, 2021
The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United StatesDaniel Katz, Brian T Bateman, Klaus Kjaer, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
Nucleic Acids Research|November 16, 2017
Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response dataAmar Koleti, Raymond Terryn, Vasileios Stathias, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Critical Care Explorations|December 8, 2022
Validating a Proteomic Signature of Severe COVID-19Christopher V Cosgriff, Todd A Miano, Divij Mathew, et al.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Allergy|March 27, 2015
Precautionary allergen labelling: perspectives from key stakeholder groupsA DunnGalvin, C-H Chan, R Crevel, et al.
CMAJ Open|March 18, 2021
Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology studyCorinne M Hohl, Rhonda J Rosychuk, Andrew D McRae, et al.
Pageof 120